Precardia

In the Know: Healthcare News for June 29, 2020

preCARDIA, Inc. Receives FDA Breakthrough Device Designation for Novel, Catheter Based Heart Failure Treatment FDA Approves First-Of-Its-Kind Percept™ PC Neurostimulator with BrainSense™ Technology Minnesota business groups oppose visa suspensions for foreign workers Blue Cross first MN health plan with role for expert guidance for gender care Cryosa Raises $8.25M in Fresh Financing Round 20 medical […]

preCARDIA, Inc. Receives FDA Breakthrough Device Designation for Novel, Catheter Based Heart Failure Treatment

Pioneering technology is designed to address Acute Decompensated Heart Failure ST. PAUL, Minn., June 23, 2020 /PRNewswire/ — preCARDIA, Inc., has announced that the company’s catheter based system for treating volume overload in patients with acutely decompensated heart failure (ADHF) has been designated for the Breakthrough Devices Program by the U.S. Food and Drug Administration (FDA). The […]

In the Know: Healthcare News from Medical Alley for December 9, 2019

John Halamka named president of Mayo Clinic Platform NeuroOne Medical Technologies Corporation Receives FDA 510(k) Clearance for Evo(TM) Cortical Electrode Abilitech Medical raises $7.4 million Dr. Craig Samitt Headlines Medical Alley Representation on TCB 100 List Boston Scientific sells Zytiga royalties for $256m Case report: Stem cells a step toward improving motor, sensory function after […]

preCARDIA Enrolls First Patient in Early Feasibility Study

Company initiates the VENUS-HF study in patients with Acute Decompensated Heart Failure (ADHF) ST. PAUL, Minn., Aug. 15, 2019 /PRNewswire/ — preCARDIA, Inc., a medical device company developing innovative technologies for the treatment of acute decompensated heart failure (ADHF), has enrolled the first patient in the VENUS-HF Early Feasibility Study at Tufts Medical Center in Boston by Dr. Carey Kimmelstiel, Director, […]

In the Know — Healthcare News for May 27, 2019

Apple Watch app for nightmare disorder receives FDA breakthrough designation, opens enrollment for two RCTs MagStim wins FDA nod, launches StimGuide TMS navigation system Buoyed by CGT growth, Bio-Techne plans plant to supply $200m of reagents Minneapolis med-tech firm SynerFuse raises $2.6M FDA Approves Extension of Treatment for Short Bowel Syndrome to Include Children Strategic […]

Keep your finger on the pulse of Medical Alley from anywhere with the ALLEY NEWSLETTER